NCT00753207View on ClinicalTrials.gov

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

March 31, 2012

Conditions
Breast Cancer
Interventions
DRUG

epirubicin hydrochloride

DRUG

lapatinib ditosylate

OTHER

biomarker analysis

OTHER

immunohistochemistry staining method

OTHER

liquid chromatography

OTHER

mass spectrometry

Trial Locations (3)

4

St Vincent's University Hospital, Dublin

8

St James's Hospital, Dublin

24

The Adelaide and Meath Hospital, Dublin Incorporating the National Childresn's Hospital, Dublin

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT00753207 - Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 | Biotech Hunter | Biotech Hunter